分泌的Clever-1调节T细胞的反应,并影响癌症免疫疗法的疗效
Stuart Prince1, Miro Viitala1, Riikka Sjöroos1
1MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland.
Theranostics
|August 4, 2025
概括
分泌的Clever-1 (sClever-1) 是癌症中的一种新型免疫抑制因子,损害T细胞的反应,降低免疫疗法的有效性. 针对sClever-1显示出作为癌症治疗的生物标志物和治疗策略的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 克利弗-1是一种食尸体受体,参与瘤免疫逃避和抵抗免疫检查点抑制剂.
- 抗Clever-1抗体Bexmarilimab正在针对固体瘤和血液恶性瘤进行临床研究.
研究的目的:
- 为了研究分泌的Clever-1 (sClever-1) 在癌症免疫力中的作用.
- 评估sClever-1作为癌症免疫治疗的潜在治疗标和生物标志物.
主要方法:
- 在乳腺癌患者和使用基于TRFIA的ELISA的临床试验参与者的sClever-1血量化.
- 重组sClever-1.0的生物物理特征
- 评估sClever-1与T细胞相互作用的功能测试,包括流细胞计和T细胞激活测试.
- 机械研究涉及细胞外囊泡,质谱和分析患者衍生的瘤扩散剂.
主要成果:
- 癌症患者的sClever-1血水平升高,在接受贝克斯马里利马布治疗后降低.
- 重组sClever-1损害了T细胞受体信号传递和Th1扩张,通过通过IGF2R与激活的T细胞结合.
- sClever-1与细胞外囊泡有关,促进了T细胞耐受性,并降低了抗PD-1的有效性.
- 在瘤扩张中,sClever-1与CD4+和CD8+T细胞结合,并增加了TGFβ分泌.
结论:
- 分泌Clever-1 (sClever-1) 是癌症中的独立免疫抑制媒介,与细胞Clever-1不同.
- sClever-1有助于瘤免疫逃避和抵抗免疫治疗.
- sClever-1代表了一个潜在的治疗标和预测生物标记物,用于指导癌症免疫治疗策略.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.1K
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
T Cell Activation and Clonal Selection
4.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.7K
Mitogens and the Cell Cycle
6.8K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.8K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
